We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$175M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$26.7M
3
SOXX icon
iShares Semiconductor ETF
SOXX
+$12.1M
4
IWD icon
iShares Russell 1000 Value ETF
IWD
+$11.3M
5
IWV icon
iShares Russell 3000 ETF
IWV
+$9.58M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHR icon
3201
Cheer Holding
CHR
$3.49M
$40K ﹤0.01%
+11
New +$57.7K
CVGI icon
3202
Commercial Vehicle Group
CVGI
$128M
$40K ﹤0.01%
3,781
+1,595
+73% +$17.6K
DTIL icon
3203
Precision BioSciences
DTIL
$208M
$40K ﹤0.01%
106
-88
-45% -$26.4K
EAF icon
3204
GrafTech
EAF
$204M
$40K ﹤0.01%
342
-593
-63% -$74.4K
ECC
3205
Eagle Point Credit Company
ECC
$501M
$40K ﹤0.01%
2,933
+2,137
+268% +$28K
FXL icon
3206
First Trust Technology AlphaDEX Fund
FXL
$2.81B
$40K ﹤0.01%
324
-14,778
-98% -$1.76M
DMRA
3207
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.85B
$40K ﹤0.01%
+315
New +$42.9K
GOVT icon
3208
iShares US Treasury Bond ETF
GOVT
$43.7B
$40K ﹤0.01%
1,500
-8,000
-84% -$211K
IAU icon
3209
iShares Gold Trust
IAU
$65.1B
$40K ﹤0.01%
1,200
-66,535
-98% -$2.3M
MATV icon
3210
Mativ Holdings
MATV
$720M
$40K ﹤0.01%
995
-1,966
-66% -$87.7K
NERV icon
3211
Minerva Neurosciences
NERV
$218M
$40K ﹤0.01%
2,175
+820
+61% +$17.7K
OSPN icon
3212
OneSpan
OSPN
$605M
$40K ﹤0.01%
1,565
-4,534
-74% -$119K
PDSB icon
3213
PDS Biotechnology
PDSB
$19M
$40K ﹤0.01%
3,191
-20,256
-86% -$158K
RELX icon
3214
RELX
RELX
$61.9B
$40K ﹤0.01%
1,525
-4,632
-75% -$123K
SSNC icon
3215
SS&C Technologies
SSNC
$18.7B
$40K ﹤0.01%
553
+111
+25% +$8.12K
ZUMZ icon
3216
Zumiez
ZUMZ
$321M
$40K ﹤0.01%
818
-3,569
-81% -$160K
XTKG
3217
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
– –
0
– –
PRSU
3218
Pursuit Attractions and Hospitality Inc
PRSU
$1.24B
$40K ﹤0.01%
793
-1,211
-60% -$53.5K
CERE
3219
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$40K ﹤0.01%
1,554
+945
+155% +$13.5K
SBOW
3220
DELISTED
SilverBow Resources, Inc.
SBOW
$40K ﹤0.01%
1,759
-420
-19% -$6.39K
GOL
3221
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$40K ﹤0.01%
4,357
+2,479
+132% +$23.1K
LMNL
3222
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$40K ﹤0.01%
1,014
+974
+2,435% +$42.4K
TCFC
3223
DELISTED
The Community Financial Corporation Common Stock
TCFC
$40K ﹤0.01%
1,143
-1,719
-60% -$61K
SPNE
3224
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$40K ﹤0.01%
1,982
+434
+28% +$8.92K
PZN
3225
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$40K ﹤0.01%
3,627
-920
-20% -$10.2K
127 128
129
130 131

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.